DB05144InvestigationalVaccines
PEV3A is a prophylactic malaria vaccine that acts against various stages of the disease. It is a two-component vaccine that contains the virosome formulated peptide mimetics PEV301 and PEV302. The... The two synthetic peptide vaccine components mimic the native structure of important antigens of the malaria parasite.
- Primary indication
- Investigated for use/treatment in malaria.Curator reviewed
What you can answer from here — as of April 02, 2025
Which companies are running trials of PEV3A, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account